Form D — Addition Therapeutics, Inc.
0002102340-25-000001 · filed 2025-12-22
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $28,000,000
- Total sold
- $28,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Addition Therapeutics, Inc.
- CIK
- 2102340
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 201 HASKINS WAY, SUITE 300
SOUTH SAN FRANCISCO, CA 94080 - Phone
- 650-430-2889
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Ronald Park · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
Peter Bisgaard · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Kathleen Collins · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Matthew Patterson · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Laetitia Schwab · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Jennifer Lee · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Jayson Punwani · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Lawrence Kong · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
View original on SEC EDGAR.